Letter: Reliability of transcutaneous PO2 with Roche Oxygen Monitor 5300 at 44 C in newborn infants with RDS.
D006801:Humans; D007231:Infant, Newborn; D008991:Monitoring, Physiologic / Q000295:instrumentation*; D010100:Oxygen / Q000378:metabolism*; D010102:Oxygen Inhalation Therapy / Q000295:instrumentation*; D012127:Respiratory Distress Syndrome, Newborn / Q000378:metabolism*
D010100:Oxygen